B-type natriuretic peptide: a critical review

W H Wilson Tang1

  • 1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. tangw@ccf.org

Insights

Natriuretic peptides aid in diagnosing heart conditions, but variations in levels require clinical context. Understanding these variations is key for accurate interpretation in patient care.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Diagnostics

Background:

  • Natriuretic peptides are established diagnostic and prognostic tools for heart failure, myocardial infarction, and coronary syndromes.
  • Despite widespread clinical use, the biological basis for variations in plasma natriuretic peptide levels remains incompletely understood.
  • Accurate interpretation of natriuretic peptide levels necessitates consideration of clinical context and potential confounders.

Purpose of the Study:

  • To explore the biological variations in plasma natriuretic peptide levels.
  • To highlight the importance of clinical context in interpreting natriuretic peptide measurements.
  • To discuss the implications of natriuretic peptide levels in diagnosing myocardial disease.

Main Methods:

  • Review of existing literature on natriuretic peptide biology and clinical applications.
  • Analysis of factors influencing intra-assay and intraindividual variability.
  • Synthesis of data regarding the diagnostic utility and limitations of natriuretic peptides.

Main Results:

  • High plasma natriuretic peptide levels strongly suggest underlying myocardial disease but lack specificity for a precise cause.
  • Variability in natriuretic peptide levels can be influenced by numerous biological and analytical factors.
  • The clinical utility of natriuretic peptides is enhanced by understanding these variations.

Conclusions:

  • Natriuretic peptides are valuable but require careful interpretation due to inherent biological variability.
  • Further research is needed to fully elucidate the factors affecting natriuretic peptide levels.
  • Investigational uses include monitoring patient management and detecting subclinical cardiac conditions.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...